Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Geratherm Medical AGXTER:GME 72 Equity-to-Asset is 0.74 as of Jun. 2026, which is 17% above its 10-year median of 0.63. GuruFocus rates XTER:GME with a GF Score™ of 72/100 and a GF Value™ of €3.13 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Geratherm Medical AG ranks better than 68.78% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Geratherm Medical AG's Total Stockholders Equity for the quarter that ended in Jun. 2026 was €19.38 Mil. Geratherm Medical AG's Total Assets for the quarter that ended in Jun. 2026 was €25.54 Mil.
Therefore, Geratherm Medical AG's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.74.
The historical rank and industry rank for Geratherm Medical AG's Equity-to-Asset or its related term are showing as below:
XTER:GME'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.55 Med: 0.63 Max: 0.76
Current: 0.76
During the past 13 years, the highest Equity to Asset Ratio of Geratherm Medical AG was 0.76. The lowest was 0.55. And the median was 0.63.
XTER:GME's Equity-to-Asset is ranked better than 68.78% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs XTER:GME: 0.76
Geratherm Medical AG (XTER:GME) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Geratherm Medical AG Equity-to-Asset Related Terms
Geratherm Medical AG Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Geratherm Medical AG's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:GME vs ABT, SYK, MDT: Equity-to-Asset Comparison
For the Medical Devices subindustry, Geratherm Medical AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Geratherm Medical AG Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Geratherm Medical AG's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Geratherm Medical AG's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Geratherm Medical AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Geratherm Medical AG (XTER:GME) has a Equity-to-Asset of 0.74 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Geratherm Medical AG and its competitors. This is 17% above median its historical median of 0.63. Over the past decade, Geratherm Medical AG's Equity-to-Asset has ranged from 0.55 to 0.76. According to the industry distribution chart, Geratherm Medical AG ranks #266 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 31.2%.
Is Geratherm Medical AG's Equity-to-Asset too high?
Geratherm Medical AG's current Equity-to-Asset of 0.74 is 17% above median its 10-year median of 0.63. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 0.76. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Geratherm Medical AG's value of 0.74 is 15.6% above this industry median. Based on the distribution chart, Geratherm Medical AG ranks #266 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Geratherm Medical AG has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Geratherm Medical AG's Equity-to-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Geratherm Medical AG ranks #266 out of 852 companies for Equity-to-Asset. This puts Geratherm Medical AG in the upper half of its industry. The industry median Equity-to-Asset is 0.64. Geratherm Medical AG's value of 0.74 is 15.6% above this benchmark. Historically, Geratherm Medical AG's own Equity-to-Asset has ranged from 0.55 to 0.76 over the past decade. While the company's 10-year median is 0.63 vs. the industry median of 0.64, Geratherm Medical AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Geratherm Medical AG's current Equity-to-Asset of 0.74 is 15.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Geratherm Medical AG and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Geratherm Medical AG's current Equity-to-Asset is 0.74, which is 17% above median its own 10-year median of 0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Geratherm Medical AG stock overvalued right now?
Based on GuruFocus' analysis, Geratherm Medical AG (XTER:GME) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.13, compared to a current price of €2.45 — trading 21.7% below its estimated fair value. The current Equity-to-Asset is 0.74, which is 17% above median its 10-year median of 0.63 and 15.6% above the Medical Devices & Instruments industry median of 0.64. Geratherm Medical AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Geratherm Medical AG (XTER:GME), the current Equity-to-Asset is 0.74 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Geratherm Medical AG (XTER:GME) Overvalued in 2026?
Based on GuruFocus' analysis, Geratherm Medical AG stock appears to be undervalued.
The current stock price of €2.45 is trading 21.7% below its estimated GF Value™ of €3.13.
GuruFocus considers Geratherm Medical AG to be Modestly Undervalued.
Key valuation signals for XTER:GME:
Equity-to-Asset: 0.74 (17% above median its 10-year median of 0.63)
GF Value™: €3.13 vs. price of €2.45 (21.7% below fair value)
Industry Position: 15.6% above the Medical Devices & Instruments median (#266 of 852)
No single metric tells the full story. See the XTER:GME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
72GF Score
Get the complete analysis for XTER:GME
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:GME has been successfully added to your 
